Engineered CD40 Antibody Eliminates Metastatic Cancers in Two Patients After Single-Tumor Injection, Sparking Expanded Trials
A redesigned CD40 agonist antibody injected into a single tumor triggered body-wide immune responses that eliminated all metastases in two patients, with nearly 200 now enrolled in follow-up trials.
4 min read3 sources